![]() |
市場調査レポート
商品コード
1467756
シングルユースバイオプロセシング市場レポート:製品タイプ、用途、最終用途、エンドユーザー、地域別、2024~2032年Single-Use Bioprocessing Market Report by Product Type, Application, End-Use, End-User, and Region 2024-2032 |
||||||
カスタマイズ可能
|
シングルユースバイオプロセシング市場レポート:製品タイプ、用途、最終用途、エンドユーザー、地域別、2024~2032年 |
出版日: 2024年04月08日
発行: IMARC
ページ情報: 英文 135 Pages
納期: 2~3営業日
|
世界のシングルユースバイオプロセシング市場規模は、2023年に161億米ドルに達しました。今後、IMARC Groupは、2024~2032年の間に16.2%の成長率(CAGR)を示し、市場は2032年までに645億米ドルに達すると予測しています。慢性疾患の蔓延、技術進歩の増加、医薬品承認や生物製剤の増加などが市場を牽引する主要要因です。
シングルユースバイオプロセシング技術は、バイオ医薬品の濾過、保存、細胞培養、混合、精製を1回限り使用するために設計されています。費用対効果が高く、時間を節約でき、柔軟性があり、廃棄の手間がかからないです。複雑な工程を省くことで生産性を向上させ、従来のバイオプロセスと比較して個人間の交差汚染のリスクを低減します。これに加えて、エネルギー、培地消費量、カーボンフットプリントを削減し、鉄鋼と比較して持続可能な製造プロセスを提供する上で有益です。ワクチン、植物細胞培養、モノクローナル抗体の効率的な製造に利用されています。また、セットアップ、バリデーション、文書化にかかるスタッフの時間も短縮できるため、シングルユースバイオプロセシング技術への需要は世界中で高まっています。
現在、世界中の大衆の間で、糖尿病、喘息、関節炎、がん、高血圧、心臓発作、脳卒中、慢性閉塞性肺疾患(COPD)などの慢性疾患の有病率が上昇していることは、市場の成長を支える重要な要因の一つです。これとは別に、世界の医薬品承認や生物製剤の増加によるシングルユースバイオプロセシングに対する需要の高まりが、市場にプラスの影響を与えています。さらに、高級ポリマー材料やプラスチック複合材料で製造された製品は、一体強度が向上するため、嗜好が高まっており、業界の投資家に有利な成長機会を提供しています。これに加えて、シングルユースバイオプロセシングシステムが提供する、人件費、材料費、投資コストの削減などの様々な利点が、市場の成長を後押ししています。これに加えて、シングルユースバイオプロセシングにおける人工知能(AI)、機械学習(ML)、エラー予測と精度向上のためのビッグデータソリューションなど、さまざまな技術的進歩の出現が市場の成長を後押ししています。さらに、医薬品を製造する際の培地調製や生物製剤の出荷におけるシングルユースバイオプロセシングの利用が拡大していることも、良好な市場展望をもたらしています。これに伴い、シングルユースバイオプロセシングは、従来のバイオプロセシングに比べて二酸化炭素(CO2)の量を削減できるため、採用が増加しており、市場の成長を後押ししています。さらに、世界中の医療施設の改善によりシングルユースバイオプロセシングの採用が増加していることも、市場の成長に寄与しています。
The global single-use bioprocessing market size reached US$ 16.1 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 64.5 Billion by 2032, exhibiting a growth rate (CAGR) of 16.2% during 2024-2032. The growing prevalence of chronic diseases, increasing technological advancements, and rising number of drug approvals and biologics represent some of the key factors driving the market.
Single-use bioprocessing technology is designed for filtration, storage, cell culture, mixing, and purification of biopharmaceutical products for one-time use. It is cost-effective, timesaving, and provides flexibility and hassle-free disposal. It assists in increasing productivity by eliminating complex steps and reduces the risks of cross-contamination among individuals as compared to traditional bioprocessing. Besides this, it is beneficial in reducing energy, media consumption, and carbon footprint and providing a sustainable manufacturing process as compared to steel. It is utilized for the effective production of vaccines, plant cell cultivation, and monoclonal antibodies. As it also reduces the time of staff members for set-up, validation, and documentation, the demand for single-use bioprocessing technology is increasing across the globe.
Presently, the rising prevalence of chronic diseases, such as diabetes, asthma, arthritis, cancer, hypertension, heart attack, stroke, and chronic obstructive pulmonary disease (COPD), among the masses across the globe represents one of the key factors supporting the growth of the market. Apart from this, the growing demand for single-use bioprocessing due to the increasing number of drug approvals and biologics around the world is positively influencing the market. Additionally, rising preferences of products manufactured from high-grade polymer materials and plastic composites, as they offer enhanced integral strength, is offering lucrative growth opportunities to industry investors. Besides this, various benefits offered by single-use bioprocessing systems, such as lower labor, material, and investment costs, are propelling the growth of the market. In addition to this, the emergence of various technological advancements, such as artificial intelligence (AI), machine learning (ML), and big data solutions in single-use bioprocessing for predicting errors and improving accuracy, is bolstering the growth of the market. Moreover, the growing utilization of single-use bioprocessing in media preparation and shipping of biologics while manufacturing pharmaceuticals is offering a favorable market outlook. In line with this, the rising adoption of single-use bioprocessing, as it reduces the amount of carbon dioxide (CO2) compared to traditional bioprocessing, is impelling the growth of the market. Furthermore, the increasing employment of single-use bioprocessing due to the improving healthcare facilities across the globe is contributing to the growth of the market.
IMARC Group provides an analysis of the key trends in each sub-segment of the global single-use bioprocessing market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on product type, application, end-use and, end-user.
Media Bags and Containers
Filtration Assemblies
Single-Use Bioreactors
Disposable Mixers
Others
The report has provided a detailed breakup and analysis of the single-use bioprocessing market based on the product type. This includes media bags and containers, filtration assemblies, single-use bioreactors, disposable mixers, and others. According to the report, media bags and containers represented the largest segment.
Filtration
Storage
Cell Culture
Mixing
Purification
A detailed breakup and analysis of the single-use bioprocessing market based on the application has also been provided in the report. This includes filtration, storage, cell culture, mixing, and purification. According to the report, filtration accounted for the largest market share.
Upstream
Fermentation
Downstream
A detailed breakup and analysis of the single-use bioprocessing market based on the end-use has also been provided in the report. This includes upstream, fermentation, and downstream. According to the report, upstream accounted for the largest market share.
Biopharmaceutical Manufacturers
Life Science R&D
Others
A detailed breakup and analysis of the single-use bioprocessing market based on the end-user has also been provided in the report. This includes biopharmaceutical manufacturers, life science R&D, and others. According to the report, biopharmaceutical manufacturers accounted for the largest market share.
North America
United States
Canada
Europe
Germany
France
United Kingdom
Italy
Spain
Russia
Others
Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Others
Latin America
Brazil
Mexico
Argentina
Colombia
Chile
Peru
Others
Middle East and Africa
Turkey
Saudi Arabia
Iran
United Arab Emirates
Others
The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, Argentina, Colombia, Chile, Peru, and others); and the Middle East and Africa (Turkey, Saudi Arabia, Iran, United Arab Emirates, and others). According to the report, North America (the United States and Canada) was the largest market for single-use bioprocessing. Some of the factors driving the North America single-use bioprocessing market included the presence of large-scale manufacturing units, rising geriatric population, increasing healthcare expenditure, etc.
The report has also provided a comprehensive analysis of the competitive landscape in the global single-use bioprocessing market. Competitive analysis such as market structure, market share by key players, player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided. Some of the companies covered include Applikon Biotechnology, Boehringer Ingelheim, Cesco Bioengineering Company, Corning Inc., Danaher Corporation, Entegris, Eppendorf AG, Finesse Solutions Inc., GE Healthcare, Infors, Merck Millipore, Rentschler Biotechnologie, Sartorius Stedim Biotech, Thermo Fisher Scientific Inc., 3M Company, etc. Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.